IL162562A0 - Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid - Google Patents
Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidInfo
- Publication number
- IL162562A0 IL162562A0 IL16256202A IL16256202A IL162562A0 IL 162562 A0 IL162562 A0 IL 162562A0 IL 16256202 A IL16256202 A IL 16256202A IL 16256202 A IL16256202 A IL 16256202A IL 162562 A0 IL162562 A0 IL 162562A0
- Authority
- IL
- Israel
- Prior art keywords
- drug
- substituted
- imidazolid
- diagnosis
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10163239A DE10163239A1 (en) | 2001-12-21 | 2001-12-21 | Substituted imidazolidines, process for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them |
| PCT/EP2002/013921 WO2003053434A1 (en) | 2001-12-21 | 2002-12-09 | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162562A0 true IL162562A0 (en) | 2005-11-20 |
Family
ID=7710363
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16256202A IL162562A0 (en) | 2001-12-21 | 2002-12-09 | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid |
| IL162562A IL162562A (en) | 2001-12-21 | 2004-06-16 | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL162562A IL162562A (en) | 2001-12-21 | 2004-06-16 | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1461034B1 (en) |
| JP (1) | JP4571803B2 (en) |
| KR (1) | KR100959031B1 (en) |
| CN (1) | CN100339079C (en) |
| AR (1) | AR037932A1 (en) |
| AT (1) | ATE345797T1 (en) |
| AU (1) | AU2002361990B2 (en) |
| BR (1) | BR0215154A (en) |
| CA (1) | CA2470856A1 (en) |
| CO (1) | CO5590925A2 (en) |
| DE (2) | DE10163239A1 (en) |
| DK (1) | DK1461034T3 (en) |
| ES (1) | ES2275945T3 (en) |
| HR (1) | HRP20040573A2 (en) |
| HU (1) | HUP0600836A2 (en) |
| IL (2) | IL162562A0 (en) |
| MA (1) | MA27149A1 (en) |
| MX (1) | MXPA04005388A (en) |
| MY (1) | MY134344A (en) |
| NO (1) | NO20043009L (en) |
| PE (1) | PE20030741A1 (en) |
| PL (1) | PL368940A1 (en) |
| RS (1) | RS53204A (en) |
| RU (1) | RU2004122415A (en) |
| TW (1) | TW200305408A (en) |
| WO (1) | WO2003053434A1 (en) |
| ZA (1) | ZA200404149B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10323701A1 (en) | 2003-05-22 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Process for the synthesis of heterocyclic compounds |
| ES2545903T3 (en) | 2003-06-30 | 2015-09-16 | Sumitomo Chemical Company, Limited | Asymmetric urea compounds and process for producing asymmetric compounds by reaction of asymmetric addition of conjugate using said compounds as catalyst |
| DE10341240A1 (en) * | 2003-09-08 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Substituted thienoimidazoles, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them |
| RS58378B1 (en) | 2014-07-25 | 2019-04-30 | Taisho Pharmaceutical Co Ltd | Phenyl tetrahydroisoquinoline compound substituted with heteroaryl |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3236857A (en) * | 1961-10-09 | 1966-02-22 | Boehringer Sohn Ingelheim | 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products |
| US3190802A (en) * | 1961-10-09 | 1965-06-22 | Boehringer Sohn Ingelheim | Shaving composition and method of using same |
| EP0070084A3 (en) * | 1981-04-24 | 1983-02-16 | Beecham Group Plc | Imidazoline derivatives |
| DE3712385A1 (en) * | 1987-04-11 | 1988-10-27 | Boehringer Ingelheim Kg | 2-(Phenylimino)imidazolidines |
| GB9313330D0 (en) * | 1993-06-28 | 1993-08-11 | Fujisawa Pharmaceutical Co | New compound and its preparation |
| EP0639573A1 (en) * | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it |
| DE4328869A1 (en) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
| KR100257129B1 (en) * | 1993-09-11 | 2000-05-15 | 성재갑 | Novel cephalosphorine antibiotics |
| US5552415A (en) * | 1993-12-21 | 1996-09-03 | Eli Lilly And Company | Method of inhibiting Alzheimer's Disease |
| DE19548812A1 (en) * | 1995-12-27 | 1997-07-03 | Hoechst Ag | Use of inhibitors of the cellular Na · + · / H · + · exchanger (NHE) for the manufacture of a medicament for respiratory stimulation |
| DE19633966A1 (en) * | 1996-08-22 | 1998-02-26 | Hoechst Ag | Phenyl-substituted alkenylcarboxylic acid guanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
| PT966465E (en) * | 1997-03-14 | 2003-11-28 | Vertex Pharma | IMFDH ENZYME INHIBITORS |
| DE19945302A1 (en) * | 1999-09-22 | 2001-03-29 | Merck Patent Gmbh | Biphenyl derivatives as NHE-3 inhibitors |
| DE19950898A1 (en) * | 1999-10-22 | 2001-04-26 | Aventis Pharma Gmbh | New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders |
| DE19960204A1 (en) * | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituted norlbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
| DE10015248A1 (en) * | 2000-03-28 | 2001-10-04 | Merck Patent Gmbh | Bisamidino compounds as NHE-3 inhibitors |
| DE10019062A1 (en) * | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia |
| DE10060292A1 (en) * | 2000-12-05 | 2002-06-20 | Aventis Pharma Gmbh | Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibition of the Na + / H + exchanger and medicament containing them |
-
2001
- 2001-12-21 DE DE10163239A patent/DE10163239A1/en not_active Withdrawn
-
2002
- 2002-12-09 PL PL02368940A patent/PL368940A1/en not_active Application Discontinuation
- 2002-12-09 RU RU2004122415/04A patent/RU2004122415A/en not_active Application Discontinuation
- 2002-12-09 JP JP2003554191A patent/JP4571803B2/en not_active Expired - Fee Related
- 2002-12-09 EP EP02796586A patent/EP1461034B1/en not_active Expired - Lifetime
- 2002-12-09 HU HU0600836A patent/HUP0600836A2/en unknown
- 2002-12-09 AT AT02796586T patent/ATE345797T1/en not_active IP Right Cessation
- 2002-12-09 CN CNB028258177A patent/CN100339079C/en not_active Expired - Fee Related
- 2002-12-09 BR BR0215154-5A patent/BR0215154A/en not_active IP Right Cessation
- 2002-12-09 CA CA002470856A patent/CA2470856A1/en not_active Abandoned
- 2002-12-09 IL IL16256202A patent/IL162562A0/en unknown
- 2002-12-09 KR KR1020047009820A patent/KR100959031B1/en not_active IP Right Cessation
- 2002-12-09 DE DE50208809T patent/DE50208809D1/en not_active Expired - Lifetime
- 2002-12-09 MX MXPA04005388A patent/MXPA04005388A/en active IP Right Grant
- 2002-12-09 ES ES02796586T patent/ES2275945T3/en not_active Expired - Lifetime
- 2002-12-09 RS YU53204A patent/RS53204A/en unknown
- 2002-12-09 DK DK02796586T patent/DK1461034T3/en active
- 2002-12-09 AU AU2002361990A patent/AU2002361990B2/en not_active Ceased
- 2002-12-09 WO PCT/EP2002/013921 patent/WO2003053434A1/en active IP Right Grant
- 2002-12-11 PE PE2002001194A patent/PE20030741A1/en not_active Application Discontinuation
- 2002-12-19 TW TW091136596A patent/TW200305408A/en unknown
- 2002-12-19 AR ARP020105018A patent/AR037932A1/en unknown
- 2002-12-20 MY MYPI20024821A patent/MY134344A/en unknown
-
2004
- 2004-05-27 ZA ZA200404149A patent/ZA200404149B/en unknown
- 2004-06-01 MA MA27709A patent/MA27149A1/en unknown
- 2004-06-16 IL IL162562A patent/IL162562A/en not_active IP Right Cessation
- 2004-06-17 CO CO04056920A patent/CO5590925A2/en not_active Application Discontinuation
- 2004-06-18 HR HR20040573A patent/HRP20040573A2/en not_active Application Discontinuation
- 2004-07-15 NO NO20043009A patent/NO20043009L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20030741A1 (en) | 2003-09-29 |
| JP4571803B2 (en) | 2010-10-27 |
| WO2003053434A1 (en) | 2003-07-03 |
| RU2004122415A (en) | 2005-03-27 |
| DE50208809D1 (en) | 2007-01-04 |
| CA2470856A1 (en) | 2003-07-03 |
| TW200305408A (en) | 2003-11-01 |
| KR20040068322A (en) | 2004-07-30 |
| HRP20040573A2 (en) | 2004-10-31 |
| ATE345797T1 (en) | 2006-12-15 |
| ZA200404149B (en) | 2006-05-31 |
| CN100339079C (en) | 2007-09-26 |
| BR0215154A (en) | 2004-10-19 |
| MY134344A (en) | 2007-12-31 |
| DK1461034T3 (en) | 2007-03-26 |
| CN1606440A (en) | 2005-04-13 |
| CO5590925A2 (en) | 2005-12-30 |
| AR037932A1 (en) | 2004-12-22 |
| PL368940A1 (en) | 2005-04-04 |
| NO20043009L (en) | 2004-07-15 |
| KR100959031B1 (en) | 2010-05-20 |
| JP2005516947A (en) | 2005-06-09 |
| ES2275945T3 (en) | 2007-06-16 |
| MA27149A1 (en) | 2005-01-03 |
| EP1461034A1 (en) | 2004-09-29 |
| IL162562A (en) | 2009-12-24 |
| DE10163239A1 (en) | 2003-07-10 |
| AU2002361990A1 (en) | 2003-07-09 |
| HUP0600836A2 (en) | 2008-04-28 |
| RS53204A (en) | 2006-10-27 |
| EP1461034B1 (en) | 2006-11-22 |
| MXPA04005388A (en) | 2004-10-11 |
| AU2002361990B2 (en) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401293A3 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
| MXPA03005018A (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use. | |
| MXPA03005019A (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use. | |
| HK1167332A1 (en) | Pharmaceutical composition, use thereof and method for making the same | |
| HK1081965A1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
| MXPA03001483A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. | |
| IL162669A0 (en) | Antichlinergic agents, method for producing the same and use thereof as medicaments | |
| MXPA03000873A (en) | Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof. | |
| HK1076095A1 (en) | Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same | |
| IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
| MXPA03001510A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. | |
| IL161893A0 (en) | 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof | |
| HK1076460A1 (en) | Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same | |
| ZA200601001B (en) | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same | |
| IL162562A0 (en) | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid | |
| AU2002348998A1 (en) | N-methyl-homocystines, use thereof and method for the production thereof | |
| MXPA03007550A (en) | Caloporoside derivatives, methods for the production thereof and their use. | |
| HK1073656A1 (en) | Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent | |
| SI1513834T1 (en) | Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same | |
| HK1051853A1 (en) | Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same. | |
| SI1509498T1 (en) | Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same | |
| SI1456212T1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
| SI1560826T1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
| SI1427730T1 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
| ZA200308591B (en) | Crystalline anticholinergic, method for its production, and use thereof in the production of a drug. |